BioSpace News Archive

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that Brian M. Culley, Chief Executive Officer, will be presenting at NobleCon16 - Noble Capital Markets’ Sixteenth Annual Investor Conference on February 18, 2020 at 2:30pm Eastern Time at the Hard Rock Hotel & Casino, Hollywood, Florida in Terrace Ballroom B.

NeuroRx will update investors at the upcoming BIO CEO conference on Monday, February 10, 2020 at 10:15am . The company’s CEO, Dr. Jonathan Javitt will be presenting an overview of recent results obtained with NRX-101, the only clinical stage drug in current development for suicidal bipolar depression. NRX-101 has been granted B

Charles J. Goodacre, DDS, MSD, FACP, was honored with the President’s Award from the American College of Prosthodontists. This award recognizes outstanding vision and leadership within the ACP and the specialty of prosthodontics.

A new study, published in Lancet Digital Health, shows the added value of AI-aided breast cancer detection from mammography images.

Sirtex Medical US Holdings, Inc. (“Sirtex”), a leading manufacturer of targeted liver cancer therapies, today announced that the shareholders of OncoSec Medical, Inc. (“OncoSec”) have approved, and the parties have closed, the strategic investment by and partnership with Sirtex and Grand Decade Developments Limited, a wholly owne

Luminex Corporation announced results for its fourth quarter and full-year ended December 31, 2019.

Leidos, a FORTUNE® 500 science and technology leader, announced the formation of a Scientific Advisory Board for its Explorations in Global Health division within the Leidos Health Group.

Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced that it has commenced an underwritten public offering of 6,000,000 shares of its common stock.